Übersetzung für "Human umbilical vein endothelial cells" in Deutsch

For the biocompatibility tests, human umbilical vein endothelial cells (HUVEC) were again used.

One of these metabolites inhibits the proliferation of VEGF-stimulated human umbilical vein endothelial cells with a similar potency to that of pazopanib, the others are 10- to 20-fold less active.

One of these metabolites inhibits the proliferation of VEGF-stimulated human umbilical vein endothelial cells with a similar potency to that of pazopanib, the others are 10- to 20- fold less active.

Endothelial cells from the human umbilical cord (HUVEC, human umbilical vein endothelial cells, PromoCell, Heidelberg) were cultured in endothelial cell growth medium (PromoCell, Heidelberg) and used after two to four passages.

Several studies have shown that endothelial cell tube formation can be inhibited by interferon both in vitro and in vivo, and recent results have confirmed that interferon-a substantially inhibits human umbilical vein endothelial cells tube formation in vitro .

The aim of the present study was to investigate selectin mediated rolling velocities of leucocytes on human cardiac microvascular endothelial cells (HCMEC) and human umbilical vein endothelial cells (HUVEC).

For an additional toxicity test of monomers of formula (I), human umbilical vein endothelial cells (HUVEC) were used.

The inhibition of proliferation is determined by incorporation of bromodesoxy-uridine (BrdU) into human umbilical vein endothelial cells (HUVECs, Promo-Cell, C-12200).

Human endothelial cells (human umbilical vein endothelial cells, HUVEC) were obtained from Cellsystems (FC-0003), cultured in Vasculife VEGF complete medium (Cellsystems, LL-1020) with 2% foetal calf serum (FCS) at 37° C./5% CO 2 and used for Tie2-ELISA measurements up to passage 8.

In order to test the inhibition of gene expression using the oligonucleotides of the invention in animal cells, in particular in human primary cells, these are directed, for example, against a human gene or the corresponding RNA thereof and assayed in human cells (HUVEC, human umbilical vein endothelial cells).

In order to test the oligonucleotides of the invention for inhibition of gene expression in human primary cells, said oligonucleotides were also directed against a human gene or the corresponding RNA and tested on human cells (HUVEC, human umbilical vein endothelial cells).

The oligoribonucleotide analogs which had been modified with phosphothioate at particular positions were used in human primary cells as follows, in order to inhibit gene expression of Edg-1 in human cells (HUVEC, human umbilical vein endothelial cells).

Human umbilical vein endothelial cells (HUVECs) in culture proliferate in response to VEGF treatment and can be used as an assay system to quantify the effects of KDR kinase inhibitors on VEGF stimulation.

The biological activity was assayed by means of a BrdU proliferation assay (Roche Diagnostics, Mannheim) on human umbilical vein endothelial cells (HUVE cells) in accordance with the manufacturer's information.

NPC stands for neuronal progenitor cells, MSC for mesenchymal stem cells, BM for bone marrow, CD34 + BM for CD34-positive BM cells (stem cells), PB for peripheral blood cells and HUVEC for human umbilical vein endothelial cells.

In order to accelerate the formation of blood vessels we applied human umbilical vein endothelial cells (HUVEC) and mesenchymal stem cells (MSC) on a cardiac patch in a precise grid structure similar to a capillary net by means of LIFT.

Additionally, the protein expression level of vascular endothelial growth factor and phosphorylated vascular endothelial growth factor was significantly down-regulated in exposed human umbilical vein endothelial cells compared to sham exposed ones.

In exposed human umbilical vein endothelial cells, cell proliferation, migration and formation of tubule-like formation was significantly dereased compared to sham exposed cells.